The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Basic Concepts in Population Modeling, Simulation, and Model‐Based Drug Development
Open accessAbstract
Modeling is an important tool in drug development; population modeling is a complex process requiring robust underlying procedures for ensuring clean data, appropriate computing platforms, adequate resources, and effective communication. Although requiring an investment in resources, it can save time and money by providing a platform for integrating all information gathered on new therapeutic agents. This article provides a brief overview of aspects of modeling and simulation as applied to many areas in drug development. CPT: Pharmacometrics & Systems Pharmacology(2012) 1, e6; doi:10.1038/psp.2012.4; advance online publication 26 September 2012
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Empirical Model Building and Response Surfaces
Freeny, A. (1988) · Technometrics · doi:10.1080/00401706.1988.10488371 · Cited by 5,235
Primary, Secondary, and Meta-Analysis of Research
GLASS, G. V. (1976) · Educational Researcher · doi:10.3102/0013189x005010003 · Cited by 4,890
Can the pharmaceutical industry reduce attrition rates?
Kola, I., & Landis, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1470 · Cited by 4,167
Holford, N. H. G., & Sheiner, L. B. (1981) · Clinical Pharmacokinetics · doi:10.2165/00003088-198106060-00002 · Cited by 1,143
Learning versus confirming in clinical drug development*
Sheiner, L. B. (1997) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(97)90160-0 · Cited by 633
Sheiner, L. B., & Beal, S. L. (1980) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01060053 · Cited by 566
Building population pharmacokineticpharmacodynamic models. I. Models for covariate effects
Mandema, J. W., Verotta, D., & Sheiner, L. B. (1992) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01061469 · Cited by 500
Mechanistic Basis of Using Body Size and Maturation to Predict Clearance in Humans
Anderson, B. J., & Holford, N. H. G. (2009) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.24.25 · Cited by 494
Lalonde, R. L., Kowalski, K. G., Hutmacher, M. M., Ewy, W., Nichols, D. J., Milligan, P. A., Corrigan, B. W., Lockwood, P. A., Marshall, S. A., Benincosa, L. J., et al. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100235 · Cited by 452
Modelling of individual pharmacokinetics for computer-aided drug dosage
Sheiner, L. B., Rosenberg, B., & Melmon, K. L. (1972) · Computers and Biomedical Research · doi:10.1016/0010-4809(72)90051-1 · Cited by 388
Cited by
Mould, D., & Upton, R. (2013) · CPT: Pharmacometrics & Systems Pharmacology · doi:10.1038/psp.2013.14 · Cited by 897
Self-citationKetamine: A Review of Clinical Pharmacokinetics and Pharmacodynamics in Anesthesia and Pain Therapy
Peltoniemi, M. A., Hagelberg, N. M., Olkkola, K. T., & Saari, T. I. (2016) · Clinical Pharmacokinetics · doi:10.1007/s40262-016-0383-6 · Cited by 672
Model Evaluation of Continuous Data Pharmacometric Models: Metrics and Graphics
Nguyen, T. H. T., Mouksassi, M., Holford, N., Al‐Huniti, N., Freedman, I., Hooker, A. C., John, J., Karlsson, M. O., Mould, D. R., Pérez Ruixo, J. J., et al. (2017) · CPT: Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12161 · Cited by 402
Self-citationMarques, L., Costa, B., Pereira, M., Silva, A., Santos, J., Saldanha, L., Silva, I., Magalhães, P., Schmidt, S., & Vale, N. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16030332 · Cited by 390
Workgroup, E. M., Marshall, S., Burghaus, R., Cosson, V, Cheung, S., Chenel, M., DellaPasqua, O., Frey, N., Hamrén, B., Harnisch, L., et al. (2016) · CPT: Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12049 · Cited by 373
Pharmacokinetic-Pharmacodynamic Modeling of Antibacterial Drugs
Nielsen, E. I., & Friberg, L. E. (2013) · Pharmacological Reviews · doi:10.1124/pr.111.005769 · Cited by 332
Upton, R., & Mould, D. (2014) · CPT: Pharmacometrics & Systems Pharmacology · doi:10.1038/psp.2013.71 · Cited by 265
Self-citationCPT: Pharmacometrics and Systems Pharmacology
van der Graaf, P. H. (2012) · CPT: Pharmacometrics & Systems Pharmacology · doi:10.1038/psp.2012.8 · Cited by 100
Clinical Pharmacokinetics and Pharmacodynamics of Naloxone
Saari, T. I., Strang, J., & Dale, O. (2024) · Clinical Pharmacokinetics · doi:10.1007/s40262-024-01355-6 · Cited by 77
Kirouac, D. C., Schaefer, G., Chan, J., Merchant, M., Orr, C., Huang, S.-M. A., Moffat, J., Liu, L., Gadkar, K., & Ramanujan, S. (2017) · npj Systems Biology and Applications · doi:10.1038/s41540-017-0016-1 · Cited by 60
A practical guide for the generation of model-based virtual clinical trials
Craig, M., Gevertz, J. L., Kareva, I., & Wilkie, K. P. (2023) · Frontiers in Systems Biology · doi:10.3389/fsysb.2023.1174647 · Cited by 52
Melin, J., Parra-Guillen, Z. P., Michelet, R., Truong, T., Huisinga, W., Hartung, N., Hindmarsh, P., & Kloft, C. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa071 · Cited by 34
Helmlinger, G., Al-Huniti, N., Aksenov, S., Peskov, K., Hallow, K. M., Chu, L., Boulton, D., Eriksson, U., Hamrén, B., Lambert, C., et al. (2017) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2017.05.028 · Cited by 33
Wong, H., Bohnert, T., Damian-Iordache, V., Gibson, C., Hsu, C.-P., Krishnatry, A. S., Liederer, B. M., Lin, J., Lu, Q., Mettetal, J. T., et al. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.04.015 · Cited by 27
Papathanasiou, T., Strathe, A., Agersø, H., Lund, T. M., & Overgaard, R. V. (2020) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13985 · Cited by 18
Plasma concentrations and dosing of 2 long-acting injectable formulations of aripiprazole
Salzman, P., Raoufinia, A., Legacy, S., Such, P., & Eramo, A. (2017) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s133433 · Cited by 15
Population pharmacokinetic of paracetamol and atorvastatin with co‐administration of semaglutide
Langeskov, E. K., & Kristensen, K. (2022) · Pharmacology Research & Perspectives · doi:10.1002/prp2.962 · Cited by 12
PharmML in Action: an Interoperable Language for Modeling and Simulation
Bizzotto, R., Comets, E., Smith, G., Yvon, F., Kristensen, N., & Swat, M. (2017) · CPT: Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12213 · Cited by 9
Metadata
- Authors
- Mould, D., & Upton, R.
- Venue
- CPT: Pharmacometrics & Systems Pharmacology
- Publisher
- Wiley
- Published
- 2012-09
- Volume
- 1
- Issue
- 9
- Pages
- 1-14
- ISSN
- 2163-8306 (ISSN-L)
- OpenAlex
- W2000741779
- Cited by
- 544
- References
- 35
- FWCI
- 16.74
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.